Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Acta Derm Venereol ; 100(16): adv00264, 2020 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-32926175

RESUMO

There is a need for unified guidance on the management of ocular manifestations of atopic dermatitis and ocular manifestations associated with dupilumab in the Nordic region (Denmark, Finland, Norway and Sweden). This initiative gathered Nordic dermatologists and ophthalmologists to identify consensus in this area using a modified Delphi process. The initiative was led by a Nordic expert panel who developed a questionnaire that was circulated to a wider group. The results informed an agenda consisting of 24 statements to be voted on using a 5-point Likert scale at a meeting in Copenhagen on 24 April 2019. A facilitator moderated discussion and revised statements according to expert feedback for a second vote when required to reach consensus. Consensus was reached for 23 statements regarding the diagnosis, treatment and referral of these patients, which we hope will improve patient management in the Nordic region.


Assuntos
Dermatite Atópica , Consenso , Técnica Delphi , Dermatite Atópica/diagnóstico , Dermatite Atópica/tratamento farmacológico , Finlândia , Humanos , Noruega , Suécia
2.
Acta Derm Venereol ; 100(1): adv00015, 2020 01 07.
Artigo em Inglês | MEDLINE | ID: mdl-31709450

RESUMO

Similarities and differences in the everyday clinical management of moderate-to-severe atopic dermatitis in Nordic countries are unknown. Using a modified Delphi approach, 15 dermatologists from Denmark, Finland, Norway and Sweden completed face-to-face and online questionnaires and participated in summary discussions to map expert opinion on the clinical management of moderate-to-severe atopic dermatitis in these Nordic countries. Through discussions, 6 adult patient profiles, reflecting common disease presentations of atopic dermatitis, were identified. Using these case profiles, diagnostic work-up, treatment goals, patient education and treatment approaches were discussed. Patient education was identified as essential for effective management. A treatment sequence of moderate-to-potent topical glucocorticosteroids and emollients, followed by systemic treatment, was recommended, allowing 3 months to ascertain systemic treatment response before switching, if necessary. Consensus was not reached on systemic treatment choice, reflecting differences in clinical practice and reimbursement between countries. Practical, case-based clinical recommendations were developed for optimal patient care.


Assuntos
Dermatite Atópica/terapia , Adulto , Técnica Delphi , Humanos , Países Escandinavos e Nórdicos
3.
Acta Derm Venereol ; 85(1): 17-23, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15848985

RESUMO

Cultures for Malassezia yeasts were taken from both normal-looking skin and lesional skin in 124 patients with atopic dermatitis, 16 patients with seborrhoeic dermatitis and from normal skin of 31 healthy controls. Positive Malassezia growth was found in fewer patients with atopic dermatitis (56%) than in patients with seborrhoeic dermatitis (88%) or in healthy controls (84%, p<0.01). In the patients with atopic dermatitis, fewer positive cultures were found in lesional (28%) than in non-lesional skin (44%, p<0.05), while positive cultures were found in 75% of both lesional and non-lesional skin of patients with seborrhoeic dermatitis (not significant). M. sympodialis dominated in patients with atopic dermatitis (46%) and in healthy controls (69%). In patients with seborrhoeic dermatitis both M. sympodialis and M. obtusa were cultured in 43%. A Malassezia species extract mixture would increase the possibility of detecting IgE sensitization to Malassezia in patients with atopic dermatitis.


Assuntos
Dermatite Atópica/microbiologia , Dermatite Seborreica/microbiologia , Malassezia/isolamento & purificação , Adolescente , Adulto , Idoso , Anticorpos Antifúngicos/sangue , Estudos de Casos e Controles , Meios de Cultura , Dermatite Atópica/imunologia , Dermatite Seborreica/imunologia , Feminino , Humanos , Imunoglobulina E/sangue , Malassezia/imunologia , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença
4.
Acta Derm Venereol ; 82(3): 179-83, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12353707

RESUMO

Thyroid hormones have an influence on the connective tissue biology of the skin and, theoretically, topically applied thyroid hormones or hormone analogues could have a stimulatory effect on collagen synthesis. In this investigation the effect of topical tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues were tested for their effect in preventing betamethasone-induced skin atrophy in the normal haired mouse. Triac, tri-iodoproprionic acid (Triprop) and the synthetically developed thyroid hormone analogue KB-026 and 2 different Triac cream formulations were applied along with betamethasone on shaved mouse skin. Triac in daily doses of 1 nmol/cm2 and higher was able to block the betamethasone-induced skin atrophy in mice skin. In high doses, Triprop and KB-026 also had a blocking effect. Triac alone had a stimulatory effect on dermal thickness. This study indicates that thyroid hormone analogues may be used to prevent corticosteroid-induced skin atrophy.


Assuntos
Anti-Inflamatórios/toxicidade , Betametasona/toxicidade , Dermatopatias/prevenção & controle , Pele/efeitos dos fármacos , Pele/patologia , Tri-Iodotironina/análogos & derivados , Tri-Iodotironina/farmacologia , Administração Tópica , Animais , Atrofia , Glucocorticoides , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Dermatopatias/induzido quimicamente
5.
Acta Derm Venereol ; 82(1): 45-7, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12013198

RESUMO

Moisturizing creams have beneficial effects in the treatment of dry, scaly skin, but they may induce adverse skin reactions. In a randomized double-blind study, 197 patients with atopic dermatitis were treated with one of the following: a new moisturizing cream with 20% glycerin, its cream base without glycerin as placebo, or a cream with 4% urea and 4% sodium chloride. The patients were asked to apply the cream at least once daily for 30 days. Adverse skin reactions and changes in skin dryness were assessed by the patient and a dermatologist. Adverse skin reactions such as smarting (a sharp local superficial sensation) were felt significantly less among patients using the 20% glycerin cream compared with the urea-saline cream, because 10% of the patients judged the smarting as severe or moderate when using glycerin cream, whereas 24% did so using urea-saline cream (p < 0.0006). No differences were found regarding skin reactions such as stinging, itching and dryness/irritation. The study showed equal effects on skin dryness as judged by the patients and the dermatologist. In conclusion, a glycerin containing cream appears to be a suitable alternative to urea/sodium chloride in the treatment of atopic dry skin.


Assuntos
Dermatite Atópica/tratamento farmacológico , Fármacos Dermatológicos/administração & dosagem , Glicerol/administração & dosagem , Cloreto de Sódio/administração & dosagem , Ureia/administração & dosagem , Administração Tópica , Adulto , Idoso , Dermatite Atópica/complicações , Dermatite Atópica/diagnóstico , Relação Dose-Resposta a Droga , Método Duplo-Cego , Esquema de Medicação , Combinação de Medicamentos , Eczema/complicações , Eczema/diagnóstico , Eczema/tratamento farmacológico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Probabilidade , Valores de Referência , Índice de Gravidade de Doença , Absorção Cutânea/efeitos dos fármacos , Estatísticas não Paramétricas , Resultado do Tratamento , Perda Insensível de Água/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA